Abstract
Chronic liver disorders are the main leading cause of morbidity and mortality data. Viral infection, toxic injury, metabolic, autoimmun, storage disorders, in the case of ongoing presence of the etiological factors, could result in fibrotic remodelling in the liver. The process is complex, not fully understood in details; cells, cytokines, chemokines release, altered secretion of hepatokines, lipotoxicity, innate immun system, gut microbiom, metal ions and free radical reactions all have a role in it. Chronic liver disorders are often symptomless, diagnosed in the stage of fibrotic tissue accumulation, liver failure or hepatocellular carcinoma formation, when the prognosis is poor, treatment options are narrow. Noninvasive, properly sensitive and specific biomarkers are the targets of studies, with them the necessity of liver biopsies can be decreased, through the follow-up of processes, progression and treatment efficacy. Authors review the processes taking part in the progression of the most frequent chronic liver disorders, emphasizing the parameters of pro/antioxidant balance, and the necessity of a combined reliable biomarker. Orv Hetil. 2020; 161(35): 1441-1448.
Highlights
Chronic liver disorders are the main leading cause of morbidity and mortality data
Noninvasive, properly sensitive and specific biomarkers are the targets of studies, with them the necessity of liver biopsies can be decreased, through the follow-up of processes, progression and treatment efficacy
[33] Kaffe ET, Rigopoulou EI, Koukoulis GK, et al Oxidative stress and antioxidant status in patients with autoimmune liver diseases
Summary
A szerzők dolgozatukkal Fehér János professzorra emlékeznek, halálának 10. évfordulóján. A májbetegségek progresszióját meghatározó tényezők, különös tekintettel a szabad gyökös reakciókra. A szerzők ismertetik a leggyakoribb idült májbetegségek progressziójában szerepet játszó folyamatokat, külön kitérve az egyes kórképekben a pro/antioxidáns egyensúlyt jellemző paraméterekre, hangsúlyozva egy kombinált biomarker szükségességét. Kulcsszavak: idült májbetegségek, szabad gyökös folyamatok, antioxidáns, biomarker. Noninvasive, properly sensitive and specific biomarkers are the targets of studies, with them the necessity of liver biopsies can be decreased, through the follow-up of processes, progression and treatment efficacy. Authors review the processes taking part in the progression of the most frequent chronic liver disorders, emphasizing the parameters of pro/antioxidant balance, and the necessity of a combined reliable biomarker. [Factors affecting liver disease progression, with emphasis on the role of free radical reactions].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.